Japan seeks to maintain domestic vaccine production capacity

Key facts

• Japan will consider ways to sustain vaccine production capacity established during the COVID-19 pandemic.
• The country experienced delays in vaccine availability due to overseas development and production.

Japan is looking into methods to maintain the vaccine production capacity that was built up during the COVID-19 pandemic. This initiative is intended to ensure the nation is better prepared for future disease outbreaks. The country faced delays in obtaining vaccines during the pandemic, partly because their development and production occurred outside of Japan.